Home » TEAM » hands-Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) About the Author View all posts by iykkv Q2 Pharma is developing small-molecule antivirulence agents against bacterial infections. Leave a Reply Click here to cancel reply.